ArticleAsian Pacific journal of cancer prevention : APJCP2026
Platelet Indices as a Biomarker in Distinguishing Benign and Malignant Breast Lesions.
Article in Asian Pacific journal of cancer prevention : APJCP, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundPlatelets possess an important biological role at several stages of various malignant diseases. Platelet activation, as manifested by platelet indices, could help establish them as a diagnostic non-invasive biomarker for use in distinguishing benign and malignant breast lumps.
objectivesTo compare various platelet indices in patients with different categories of breast lesions and among different cytological or histological grades of breast carcinoma.
methodsThis was a prospective cross-sectional analytical study conducted in the Department of Pathology at Nobel Medical College and Teaching Hospital, Biratnagar, Nepal. It included 93 cytologically and histopathologically proven cases of breast lesions over a period of 9 months from September 2024 to May 2025. Blood samples from all 93 patients and 31 healthy controls were assessed for various parameters. The ANOVA test was used to compare different platelet indices across different categories and grades of breast lesions.
resultStatistically significant differences in platelet counts, mean platelet volume, platelet-large cell ratio and platelet-lymphocyte ratio were observed when comparing the control group with the malignant group (p<0.001 in all indices), the non-neoplastic group with the malignant group (p<0.001 in all indices), and the benign group with the malignant group (p<0.001 in all indices). Platelet distribution width additionally showed significant differences between non-neoplastic group and benign group (p value 0.008). Amongst the various grades within malignant group, differences in platelet indices were not significant.
conclusionMalignant breast tumors are associated with higher levels of platelet activation and systemic inflammatory response, which are reflected in altered platelet parameters. Platelet indices may assist in distinguishing between malignant and non-malignant lesions, but are less reliable in grading the malignancy.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.